Advanced search
Publication Cover
Expert Opinion on Orphan Drugs Volume 3, 2015 - Issue 3
Submit an article Journal homepage
160
Views
6
CrossRef citations to date
0
Altmetric
Review

Pathophysiology, genetics, clinical features, diagnosis and therapeutic trials in progressive supranuclear palsy

Brent BluettUniversity of California San Diego, UC San Diego Department of Neurosciences, 8950 Villa La Jolla Drive, La Jolla, CA 92037, [email protected]
&
Irene LitvanUniversity of California San Diego, UC San Diego Department of Neurosciences, 8950 Villa La Jolla Drive, La Jolla, CA 92037, [email protected]
Pages 253-265 | Published online: 20 Feb 2015

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Ali Shoeibi, Nahid Olfati & Irene Litvan. (2018) Preclinical, phase I, and phase II investigational clinical trials for treatment of progressive supranuclear palsy. Expert Opinion on Investigational Drugs 27:4, pages 349-361.
Read now
Ali Shoeibi & Irene Litvan. (2017) Therapeutic options for Progressive Supranuclear Palsy including investigational drugs. Expert Opinion on Orphan Drugs 5:7, pages 575-587.
Read now

Articles from other publishers (4)

Susan C. Slade, Christopher Bruce, Jennifer L. McGinley, Bastiaan R. Bloem & Meg E. Morris. (2020) Patient and care partner views on exercise and structured physical activity for people with Progressive Supranuclear Palsy. PLOS ONE 15:6, pages e0234265.
Crossref
Susan C Slade, David I Finkelstein, Jennifer L McGinley & Meg E Morris. (2019) Exercise and physical activity for people with Progressive Supranuclear Palsy: a systematic review. Clinical Rehabilitation 34:1, pages 23-33.
Crossref
Susan C. Slade, Martin Underwood, Jennifer L. McGinley & Meg E. Morris. (2019) Exercise and Progressive Supranuclear Palsy: the need for explicit exercise reporting. BMC Neurology 19:1.
Crossref
Joanne E. Wittwer, Margaret Winbolt & Meg E. Morris. (2019) A Home-Based, Music-Cued Movement Program Is Feasible and May Improve Gait in Progressive Supranuclear Palsy. Frontiers in Neurology 10.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.